Rare lephants
Screener

Rhythm Pharmaceuticals, Inc.

RYTM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Feb 4, 2026
4 Feb 3, 2026 OWNERSHIP DOCUMENT
4 Feb 3, 2026 OWNERSHIP DOCUMENT
4 Feb 3, 2026 OWNERSHIP DOCUMENT
4 Feb 3, 2026 OWNERSHIP DOCUMENT
4 Feb 3, 2026 OWNERSHIP DOCUMENT
4 Feb 3, 2026 OWNERSHIP DOCUMENT
4 Feb 3, 2026 OWNERSHIP DOCUMENT
4 Feb 3, 2026 OWNERSHIP DOCUMENT
SCHEDULE 13G/A Jan 30, 2026
S-8 Jan 16, 2026 FORM S-8
8-K Jan 9, 2026 8-K
8-K Dec 19, 2025 8-K
4 Dec 15, 2025 OWNERSHIP DOCUMENT
144 Dec 11, 2025
8-K Dec 11, 2025 8-K
4 Nov 24, 2025 OWNERSHIP DOCUMENT
144 Nov 20, 2025
SCHEDULE 13G/A Nov 14, 2025
4 Nov 12, 2025 OWNERSHIP DOCUMENT
144 Nov 10, 2025
144 Nov 7, 2025
8-K Nov 7, 2025 8-K
10-Q Nov 4, 2025 10-Q
8-K Nov 4, 2025 8-K
← Newer Page 4 of 34 · 835 filings Older →